On September 25, Guolonghui announced that starting from September 25, 2024: (i) Fan Jie has resigned from the position of executive director; (ii) Hu Xubo has resigned from the position of non-executive director; (iii) Cheng Liang has been appointed as an executive director; (iv) Wang Xin has been appointed as a non-executive director.
梅斯健康(02415.HK)：程亮获委任为执行董事
Mesoblast (02415.HK): Cheng Liang appointed as executive director.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated